The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: (64Cu)-labeled PSMA-targeting particle tracer, or 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots;   Diagnostic Test: PET/MRI;   Other: Blood and urine sampling;   Procedure: laparoscopic radical prostatectomy and bilateral pelvic LN dissection Sponsors:   Memorial Sloan Kettering Cancer Center;   Elucida Oncology;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials